Comunicado sobre o uso de Omalizumabe em pacientes com Urticária Crônica Espontânea e a COVID-19 / Report on the use of Omalizumab in patients with Chronic Spontaneous Urticaria and COVID-19
Arq. Asma, Alerg. Imunol
; 4(1): 136-137, jan.mar.2020. ilus
Article
in Pt
| LILACS
| ID: biblio-1381819
Responsible library:
BR2717.9
Full text:
1
Index:
LILACS
Main subject:
Omalizumab
/
Chronic Urticaria
/
COVID-19
Limits:
Humans
Language:
Pt
Journal:
Arq. Asma, Alerg. Imunol
Journal subject:
Biologia
/
Cincia
Year:
2020
Type:
Article